English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

3554 | BEDSIDE A randomized placebo controlled trial of endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic Heart Failure (END-HF) T. Santoso1, C.W. Siu2, C. Irawan2, W.S. Chan2, I. Alwi2, K.H. Yiu2, A. Azis2, Y.L. Kwong2, H.F. Tse2. 1University of Indonesia, Faculty of Medicine, Department Cardiology & Vascular Medicine, Jakarta, Indonesia; 2Queen Mary Hospital, Hong Kong, Hong Kong SAR, People’s Republic of China

european heart journal

A randomized placebo controlled trial of endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic Heart Failure (END-HF)